Trial Details
COMPLETEDBasic Information
| Clinical ID | c1792 |
|---|---|
| Identifier | NCT02394028 |
| Trial Title | A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Etrolizumab|DRUG: Placebo |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Arcadia |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-03-20 |
|---|---|
| Primary Completion Date | 2021-09-07 |
| Completion Date | 2021-09-07 |